CTI BioPharma Corp.

NASDAQ: CTIC · Real-Time Price · USD
9.10
0.01 (0.11%)
At close: Jun 23, 2023, 9:58 PM

CTI BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-13.42M -17.46M -15.71M -22.65M -37.17M -36.79M -24.18M -19.68M -17.27M
Depreciation & Amortization
520K 532K 532K 570K 317K 131K 132K 128K 135K
Stock-Based Compensation
2.5M 2.99M 2.82M 2.54M 1.68M n/a n/a n/a n/a
Other Working Capital
23.19M -7.53M -2.48M 3.31M 454K -347K n/a n/a 617K
Other Non-Cash Items
2.69M 2.6M 2.25M 2.33M 560K -61K 24K 23K -99K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-23.38M -4.18M -5.36M -3.03M 4.64M 5.24M 2.16M 943K -479K
Operating Cash Flow
-31.1M -15.51M -15.46M -20.24M -29.98M -30.02M -20.5M -17.59M -16.78M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-14.74M -29.46M -29.6M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
30M 30M 10M n/a n/a n/a n/a 4M 8M
Other Investing Acitivies
n/a 29.79M n/a -54.79M n/a n/a n/a n/a n/a
Investing Cash Flow
15.26M 537K -19.6M -54.79M n/a n/a n/a 4M 8M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
9.63M 13.35M 1.02M 1K 61.43M 188K 43.9M 52.37M 1.49M
Financial Cash Flow
9.63M 13.35M 1.02M 44.22M 61.43M 188K 43.9M 52.37M 1.49M
Net Cash Flow
-6.21M -1.63M -34.04M -30.81M 31.46M -29.83M 23.39M 38.78M -7.29M
Free Cash Flow
-31.1M -15.51M -15.46M -20.24M -29.98M -30.02M -20.5M -17.59M -16.78M